EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bilirubin ameliorates osteoarthritis via activating Nrf2/HO‐1 pathway and suppressing NF‐κB signalling

Xinyu Zhao iD, Baiqun Duan, Jianing Wu, Lihui Huang, Sheng Dai, Jie Ding, Meng Sun, Xinlu Lin, Yiling Jiang, Tuyue Sun, Ruijie Lu, Huirong Huang und 4 weitere

Journal of Cellular and Molecular Medicine · 2024-04 · 28 (7)

DOI: 10.1111/jcmm.18173 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 17.03.2024. Verfasst von Xinyu Zhao und 15 weiteren Autor:innen. Beteiligte Einrichtung: Wenzhou Municipal Key Laboratory of Pediatric Pharmacy, Department of Pharmacy, The Second Affiliated Hospital and Yuying Children's Hospital of Wenz…. Hauptthemen laut MEDLINE: NF-kappa B, Osteoarthritis. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Medical and Health Science and Technology Program, Zhejiang Medical Doctor Association, Wenzhou Municipal Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is a chronic degenerative joint disease that affects worldwide. Oxidative stress plays a critical role in the chronic inflammation and OA progression. Scavenging overproduced reactive oxygen species (ROS) could be rational strategy for OA treatment. Bilirubin (BR) is a potent endogenous antioxidant that can scavenge various ROS and also exhibit anti‐inflammatory effects. However, whether BR could exert protection on chondrocytes for OA treatment has not yet been elucidated. Here, chondrocytes were exposed to hydrogen peroxide with or without BR treatment. The cell viability was assessed, and the intracellular ROS, inflammation cytokines were monitored to indicate the state of chondrocytes. In addition, BR was also tested on LPS‐treated Raw264.7 cells to test the anti‐inflammation property. An in vitro bimimic OA microenvironment was constructed by LPS‐treated Raw264.7 and chondrocytes, and BR also exert certain protection for chondrocytes by activating Nrf2/HO‐1 pathway and suppressing NF‐κB signalling. An ACLT‐induced OA model was constructed to test the in vivo therapeutic efficacy of BR. Compared to the clinical used HA, BR significantly reduced cartilage degeneration and delayed OA progression. Overall, our data shows that BR has a protective effect on chondrocytes and can delay OA progression caused by oxidative stress.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BOsteoarthritisHumansNF-E2-Related Factor 2Reactive Oxygen SpeciesBilirubinLipopolysaccharidesInflammationChondrocytesInterleukin-1beta

Stichwörter der Autor:innen

Nrf2/HO-1anti-inflammationantioxidantbilirubinosteoarthritis

Substanzen

NF-kappa BNF-E2-Related Factor 2Reactive Oxygen SpeciesBilirubinLipopolysaccharidesInterleukin-1beta

Autor:innen und Institutionen

  • Wenzhou Municipal Key Laboratory of Pediatric Pharmacy, Department of Pharmacy, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
  • Key Laboratory of Structural Malformations in Children of Zhejiang Province, Wenzhou, China.
  • Zhejiang Engineering Research Center for Innovation and Application of Intelligent Radiotherapy Technology, Wenzhou, China.
  • School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
  • Zhejiang-Hong Kong Precision Theranostics of Thoracic Tumors Joint Laboratory, Wenzhou, China.

ORCID-Profile: Xinyu Zhao, Longfa Kou

Förderung

  • Zhejiang Medical and Health Science and Technology Program
  • Zhejiang Medical Doctor Association
  • Wenzhou Municipal Science and Technology Bureau
  • Natural Science Foundation of Zhejiang Province
  • Health Commission of Zhejiang Province
  • Health Innovation Talents Program

Zitieren

APA

Zhao, X., Duan, B., Wu, J., Huang, L., Dai, S., Ding, J., Sun, M., Lin, X., Jiang, Y., Sun, T., Lu, R., Huang, H., Lin, G., Chen, R., Yao, Q., & Kou, L. (2024). Bilirubin ameliorates osteoarthritis via activating Nrf2/HO‐1 pathway and suppressing NF‐κB signalling. Journal of Cellular and Molecular Medicine, 28(7). https://doi.org/10.1111/jcmm.18173

Vancouver

Zhao X, Duan B, Wu J, Huang L, Dai S, Ding J, et al. Bilirubin ameliorates osteoarthritis via activating Nrf2/HO‐1 pathway and suppressing NF‐κB signalling. Journal of Cellular and Molecular Medicine. 2024;28(7). doi:10.1111/jcmm.18173

BibTeX
@article{Zhao2024,
  author = {Zhao, Xinyu and Duan, Baiqun and Wu, Jianing and Huang, Lihui and Dai, Sheng and Ding, Jie and Sun, Meng and Lin, Xinlu and Jiang, Yiling and Sun, Tuyue and Lu, Ruijie and Huang, Huirong and Lin, Guangyong and Chen, Ruijie and Yao, Qing and Kou, Longfa},
  title = {Bilirubin ameliorates osteoarthritis via activating Nrf2/HO‐1 pathway and suppressing NF‐κB signalling},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  volume = {28},
  number = {7},
  doi = {10.1111/jcmm.18173}
}
Kostenlos starten →